By expenditures
| Name | Title | Type |
|---|---|---|
| Angie Hillestad | Partner | Auditee |
| Michael Vansurksum | Vice President For Business And Finance | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375367 | 2025 | 2025-12-17 | EIDE BAILLY LLP | $12.06M |
| 328325 | 2024 | 2024-11-14 | Eide Bailly LLP | $11.98M |
| 6499 | 2023 | 2023-12-13 | Eide Bailly LLP | $12.46M |
| 38495 | 2022 | 2022-12-19 | Eide Bailly LLP | $15.59M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 375367 | 2025 | 2025-12-17 | 1165103 | 2025-002 | Material Weakness | Yes | L |
| 328325 | 2024 | 2024-11-14 | 1084261 | 2024-005 | Material Weakness | - | L |
| 328325 | 2024 | 2024-11-14 | 1084260 | 2024-004 | Significant Deficiency | - | N |
| 328325 | 2024 | 2024-11-14 | 1084259 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 1084258 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 1084257 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 1084256 | 2024-002 | Significant Deficiency | - | E |
| 328325 | 2024 | 2024-11-14 | 507819 | 2024-005 | Material Weakness | - | L |
| 328325 | 2024 | 2024-11-14 | 507818 | 2024-004 | Significant Deficiency | - | N |
| 328325 | 2024 | 2024-11-14 | 507817 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 507816 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 507815 | 2024-003 | Significant Deficiency | - | L |
| 328325 | 2024 | 2024-11-14 | 507814 | 2024-002 | Significant Deficiency | - | E |
| 38495 | 2022 | 2022-12-19 | 618170 | 2022-004 | Material Weakness | Yes | I |
| 38495 | 2022 | 2022-12-19 | 618169 | 2022-003 | Material Weakness | - | AB |
| 38495 | 2022 | 2022-12-19 | 41728 | 2022-004 | Material Weakness | Yes | I |
| 38495 | 2022 | 2022-12-19 | 41727 | 2022-003 | Material Weakness | - | AB |